The trends in the stock market are constantly changing, and it takes a great deal of hard work and decades of market experience to know what’s coming next. I’ve seen these trends come and go multiple times over the years; sectors will rotate and latecomers will get hammered every time. I know one thing for sure, though: the legal cannabis industry is flourishing as I write this, and it’s not just a short-term trend. It’s the real deal, and it’s here to stay.

The facts make it perfectly evident that any stigma attached to the marijuana plant is a thing of the past, a relic of bygone days when fear and misunderstanding dominated the headlines and politicians distorted the facts for their own benefit. Scientific breakthroughs and medical advances, combined with agricultural technologies that were unimaginable only a few years ago, have changed attitudes and governmental policies at a breakneck pace.

Even the mainstream media is starting to catch on, believe it or not, though of course they’re a lagging indicator as usual. To show you an illustration of this, check out this headline I just found in Newsweek online:

Courtesy of Newsweek online

Yes, marijuana legalization is on a roll; I certainly won’t argue with that. And there’s no question that Canada is launching a legal marijuana market: they’ve been doing this for years! Canada is a progressive and forward-thinking nation when it comes to cannabis, and full legalization (including adult recreational use) has been supported by the majority of Canadian citizens for quite a while now:

Courtesy of CTV News/Nanos Research

Canadian Prime Minister Justin Trudeau has shown his full support for cannabis legalization, thereby giving the green light and eliminating all roadblocks:

Courtesy of Twitter, Newsweek online

In the United States, cannabis products are fully legal for both medicinal and adult recreational uses in nine states as well as Washington, D.C. Cannabis for medical use is legally permitted in a total of 31 states, plus there are 12 states that allow cannabis use for specific medical conditions. In addition to all of this, there are several U.S. states that have ballot measures coming up later this year. If Mexico legalizes for all uses – and the incoming government has suggested that it may do this – the entire length of North America’s Pacific Coast will be unified soon as 100% legalized. Honestly, there’s no hope for anyone who want to suppress cannabis legalization in North America.

Without a doubt, great wealth can come to investors who place their bets early in this fascinating and highly lucrative North American market. The research team at Crush the Street has been following this industry and seeking out a company that will richly reward investors who are prepared to make a fortune in legalized cannabis, and I am informing you today that we’ve identified this company as C21 Investments Inc. (CSE:CXXI). Based in Vancouver, C21 is a vertically integrated cannabis corporation that cultivates, processes, manufactures, and distributes quality cannabis and hemp-derived consumer products with branding recognition in the United States and internationally. All of my team’s research and due diligence have led me to the conclusion that C21 will provide enormous returns in 2018.

And 2018, which will be amazing for C21, will be just the beginning. As an investor, how does an 86% increase in projected revenues in 2018 and 2019 sound? To me, it sounds like enormous profit potential:

Courtesy of C21 Investments Inc. Investor Presentation

Profitable vertically integrated operations, with expert leadership in a growth-oriented industry that’s spreading quickly across North America and throughout the world… This will be my biggest winner of 2018 and 2019. Take a serious look at CXXI stock and consider a position – your cannabis fortune is ready for the taking.

Prosperous Regards,
Kenneth Ameduri
Chief Editor,


Legal Notice: This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

Never base any decision off of our emails. stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish.  Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. We have been compensated by C21 Investments Inc. a digital marketing fee of three hundred thousand dollars USD. We have also received a signing fee of five hundred thousand dollars CAD. We have also been issued 1,800,000 RSUs. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at